|
 |
|
Pinnacle |
| The accent of the Company on chronic and lifestyle ailments is aided by this division. Through Pinnacle, the Company provides a judicious mélange of drugs addressing chronic and lifestyle diseases, those are constantly on the rise. It caters to a specialist’s group comprising Cardiologists, and Consulting Physicians. ORG IMS estimates the Cardiac Market in India to be around Rs.34,847
mn with a growth rate of 23.4%. In the CVS segment, Lupin commands a 5.1% market share and is positioned in the top 10 companies for this segment.
Key Products : Pinnacle
|
Product |
Therapeutic Segment |
Product Rank In the relevant segment |
|
Clopitab
|
CVS |
1 |
|
Tonact
|
CVS |
2 |
|
Ramistar
|
CVS |
2 |
|
Lupenox
|
CVS |
2 |
|
Nebistar
|
CVS |
2 |
| |
